Poukalov Konstantin

Poukalov Konstantin is listed in filings as Director at Lyra Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 14, 2024, including 1 public disclosure. Recent filings connect the profile to Lyra Therapeutics, Inc. (LYRA). The current snapshot covers public activity from Jun 14, 2024. Reported amounts are shown as $9.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.